ACW ASX Chart
Snapshot
Actinogen Medical Limited (ACW, formerly Actinogen Limited) is an ASX-listed biotechnology company developing innovative treatments for Alzheimer's disease and the cognitive decline associated with neurodegenerative diseases and metabolic diseases, like Type 2 diabetes. It focusses on the development of Xanamem, a novel treatment for Alzheimer's disease and the cognitive deficiency associated with other neurological and metabolic diseases within Australia.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2023 YTD | |
1 Year | |
vs Sector (1yr) | -67.49% |
vs ASX 200 (1yr) | -75.85% |
Latest Actinogen Medical Ltd News
Announcements
Corporate Overview
Corporate Details
Head Office | Sydney NSW 2000 |
Website | - |
Registry | Automic Group |
Auditor | Ernst & Young |
Date Listed | - |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
21/02/2024 | Report (Interim) |
28/08/2024 | Report (Prelim) |
28/08/2024 | Report (Annual) |
11/10/2024 | Report (Annual) |
Former Company Names
- Actinogen Limited (ACW), 17/11/2015
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
ACW directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of ACW directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
BVF Partners L.P | 15/09/2023 | 247,334,680 | 11.16 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
No buy transactions reported by Substantial Shareholders in the past 12 months.
Shareholders Selling
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2023 | $0.040 | 30 June |
2022 | $0.050 | 30 June |
2021 | $0.130 | 30 June |
2020 | $0.022 | 30 June |
2019 | $0.010 | 28 June |
2018 | $0.048 | 29 June |
2017 | $0.061 | 28 June |
2016 | $0.072 | 28 June |
2015 | $0.072 | 30 June |
2014 | $0.011 | 30 June |

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.